Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
N Engl J Med
    November 2017
  1. JACOB KA, Gianoli M, van Dijk D
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897-8.
    >> Share

  2. TAGGART DP, Puskas JD
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897.
    >> Share

  3. JONES SG, Pullan MD, Kirmani BH
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1896-7.
    >> Share

  4. NOZAWA T, Imagawa T, Ito S
    Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease.
    N Engl J Med. 2017;377:1894-1896.
    >> Share


  5. Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1898-1899.
    >> Share

    October 2017
  6. THIELE H, Akin I, Sandri M, Fuernau G, et al
    PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
    N Engl J Med. 2017 Oct 30. doi: 10.1056/NEJMoa1710261.
    >> Share

  7. MONTONE RA, Minelli S
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595-6.
    >> Share

  8. AGGARWAL S, Pavlides G
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595.
    >> Share

  9. BHATT DL
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1598-1599.
    >> Share

  10. DAVIES JE, Sen S, Escaned J
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1597-1598.
    >> Share

  11. PIJLS NHJ, De Bruyne B
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596.
    >> Share


  12. Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596-7.
    >> Share

    September 2017
  13. BOWMAN L, Hopewell JC, Chen F, Wallendszus K, et al
    Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
    N Engl J Med. 2017;377:1217-1227.
    >> Share

  14. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med. 2017;377:1119-1131.
    >> Share

  15. HOLMAN RR, Bethel MA, Mentz RJ, Thompson VP, et al
    Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017 Sep 14. doi: 10.1056/NEJMoa1612917.
    >> Share

    August 2017
  16. HOFMANN R, James SK, Jernberg T, Lindahl B, et al
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2017 Aug 28. doi: 10.1056/NEJMoa1706222.
    >> Share

  17. LOSCALZO J
    Is Oxygen Therapy Beneficial in Acute Myocardial Infarction? Simple Question, Complicated Mechanism, Simple Answer.
    N Engl J Med. 2017 Aug 28. doi: 10.1056/NEJMe1709250.
    >> Share

  18. ERLINGE D, Omerovic E, Frobert O, Linder R, et al
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMoa1706443.
    >> Share

  19. STONE GW
    Procedural Anticoagulation in Myocardial Infarction.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMe1709247.
    >> Share

  20. EIKELBOOM JW, Connolly SJ, Bosch J, Dagenais GR, et al
    Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMoa1709118.
    >> Share

  21. HARRINGTON RA
    Targeting Inflammation in Coronary Artery Disease.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMe1709904.
    >> Share

  22. REDBERG RF, Prasad V
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:786-7.
    >> Share

  23. NACI H, Mehra MR
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:785-6.
    >> Share

  24. GARCIA DE TENA J, Morales-Ortega A, Pindao-Quesada G
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:785.
    >> Share

  25. NUNES JPL
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:787.
    >> Share

  26. KOSKINAS KC, Windecker S
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:786.
    >> Share

  27. SABATINE MS, Giugliano RP, Pedersen TR
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:787-8.
    >> Share

  28. SHROYER AL, Hattler B, Wagner TH, Collins JF, et al
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:623-632.
    >> Share

    July 2017
  29. BIBAS L, Thanassoulis G
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017;377:396-7.
    >> Share

  30. FERRANTE G, Stefanini GG
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017;377:397.
    >> Share


  31. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017;377:397-8.
    >> Share

  32. MARTINEZ-CERON E, Garcia-Rio F
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;377:300.
    >> Share


  33. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;377:300-301.
    >> Share

  34. CHRISTEN T, de Mutsert R
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:95.
    >> Share


  35. Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:94-96.
    >> Share

  36. XU L, Li D
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:94.
    >> Share

  37. MIHAS C, Kantzanou M
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:94.
    >> Share

  38. JANI SM, Nallamothu BK, Cooper LT, Smith A, et al
    Beating, Fast and Slow.
    N Engl J Med. 2017;377:72-78.
    >> Share

    June 2017
  39. KONDO T, Terada K
    Coronary-Artery Vasospasm.
    N Engl J Med. 2017;376:e52.
    >> Share

  40. JAISWAL S, Natarajan P, Silver AJ, Gibson CJ, et al
    Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
    N Engl J Med. 2017 Jun 21. doi: 10.1056/NEJMoa1701719.
    >> Share

  41. WYKRZYKOWSKA JJ, Kraak RP, Hofma SH, van der Schaaf RJ, et al
    Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
    N Engl J Med. 2017;376:2319-2328.
    >> Share

  42. NEAL B, Perkovic V, Mahaffey KW, de Zeeuw D, et al
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017 Jun 12. doi: 10.1056/NEJMoa1611925.
    >> Share

    May 2017
  43. ANDERSON JL, Morrow DA
    Acute Myocardial Infarction.
    N Engl J Med. 2017;376:2053-2064.
    >> Share

  44. DEWEY FE, Gusarova V, Dunbar RL, O'Dushlaine C, et al
    Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.
    N Engl J Med. 2017 May 24. doi: 10.1056/NEJMoa1612790.
    >> Share

  45. GRAHAM MJ, Lee RG, Brandt TA, Tai LJ, et al
    Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.
    N Engl J Med. 2017 May 24. doi: 10.1056/NEJMoa1701329.
    >> Share

  46. LINCOFF AM, Nicholls SJ, Riesmeyer JS, Barter PJ, et al
    Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
    N Engl J Med. 2017;376:1933-1942.
    >> Share

  47. BHATT DL
    Assessment of Stable Coronary Lesions.
    N Engl J Med. 2017;376:1879-1881.
    >> Share

  48. WANG DSH, Mazer CD, Orser BA
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1891-2.
    >> Share

  49. JIMENEZ-RIVERA JJ, Iribarren-Sarrias JL, Martinez-Sanz R
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1891.
    >> Share

  50. MYLES PS, Smith JA, Painter T
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1893.
    >> Share

  51. MILOJEVIC M, Kappetein AP, Head SJ
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1892.
    >> Share

  52. DAWES TJ, Price S
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1892-3.
    >> Share

  53. DAVIES JE, Sen S, Dehbi HM, Al-Lamee R, et al
    Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI.
    N Engl J Med. 2017;376:1824-1834.
    >> Share

  54. GOTBERG M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, et al
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI.
    N Engl J Med. 2017;376:1813-1823.
    >> Share

    April 2017
  55. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;376:1407-1418.
    >> Share

  56. JENA AB, Mann NC, Wedlund LN, Olenski A, et al
    Delays in Emergency Care and Mortality during Major U.S. Marathons.
    N Engl J Med. 2017;376:1441-1450.
    >> Share

  57. PACKER M, O'Connor C, McMurray JJ, Wittes J, et al
    Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure.
    N Engl J Med. 2017 Apr 12. doi: 10.1056/NEJMoa1601895.
    >> Share

  58. BANGALORE S, Fayyad R, Laskey R, DeMicco DA, et al
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;376:1332-1340.
    >> Share

  59. KERALIYA A, Blankstein R
    Regression of Coronary Atherosclerosis with Medical Therapy.
    N Engl J Med. 2017;376:1370.
    >> Share

  60. NISSEN SE
    Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
    N Engl J Med. 2017;376:1390.
    >> Share

  61. GROSSER T
    Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
    N Engl J Med. 2017;376:1389.
    >> Share

    March 2017
  62. DEFILIPPIS EM, Vaidya A, Ramani S, French C, et al
    Under Pressure.
    N Engl J Med. 2017;376:e23.
    >> Share

  63. KULLO IJ, Fan X, Ding K
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1192-3.
    >> Share

  64. ELLISON DH
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1194.
    >> Share

  65. RAPPAPORT SM, Neophytou AM
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1193.
    >> Share


  66. Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1194-5.
    >> Share

  67. MEHTA RH, Leimberger JD, van Diepen S, Meza J, et al
    Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    N Engl J Med. 2017 Mar 19. doi: 10.1056/NEJMoa1616218.
    >> Share

  68. KOBER L
    Complete Revascularization in ST-Elevation Myocardial Infarction?
    N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMe1702825.
    >> Share

  69. SMITS PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, et al
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMoa1701067.
    >> Share

  70. RAY KK, Landmesser U, Leiter LA, Kallend D, et al
    Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615758.
    >> Share

  71. RIDKER PM, Revkin J, Amarenco P, Brunell R, et al
    Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1701488.
    >> Share

  72. DULLAART RP
    PCSK9 Inhibition to Reduce Cardiovascular Events.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMe1703138.
    >> Share

  73. SABATINE MS, Giugliano RP, Keech AC, Honarpour N, et al
    Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615664.
    >> Share

  74. BELLEYCOTE EP, Lamy AR, Whitlock RP
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1087-8.
    >> Share

  75. CHRISTIANSEN EH, Makikallio T, Holm NR
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1088-9.
    >> Share


  76. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1089.
    >> Share

  77. LIKOSKY DS, Baker RA
    Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2017;376:894.
    >> Share

  78. IPP E, Genter P, Childress K
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890-1.
    >> Share


  79. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;379:890-1.
    >> Share

  80. COSMI F, Laini R, Nicolucci A
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890.
    >> Share


  81. Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2017;376:894-895.
    >> Share

  82. WILLIAMS TC, Stewart E
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891.
    >> Share


  83. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891-2.
    >> Share

    December 2016
  84. FARSHID A
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2604.
    >> Share

  85. URBAN P, Oldroyd K, Krackhardt F
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2603-2604.
    >> Share


  86. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2602-2605.
    >> Share

  87. BANGALORE S
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
    N Engl J Med. 2016;375:2602-3.
    >> Share

  88. VORA AN, Rao SV, Stone GW
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2602.
    >> Share

  89. TAGGART DP, Altman DG, Gray AM, Lees B, et al
    Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts.
    N Engl J Med. 2016;375:2540-9.
    >> Share

  90. BATES ER
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2605.
    >> Share

  91. KHERA AV, Emdin CA, Drake I, Natarajan P, et al
    Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease.
    N Engl J Med. 2016;375:2349-2358.
    >> Share

  92. O'DONNELL M, Mann JF, Schutte AE, Staessen JA, et al
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2404-2408.
    >> Share


  93. Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2404-2408.
    >> Share

  94. JOHNS DM
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2407.
    >> Share

  95. GRAUDAL N
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2405-6.
    >> Share

  96. ALDERMAN MH
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2405.
    >> Share

  97. SNIDERMAN AD, Thanassoulis G
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2304.
    >> Share

  98. MORRISON AC, Fu YP, O'Donnell CJ
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303.
    >> Share


  99. Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303-2306.
    >> Share

  100. STITZIEL NO
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2306.
    >> Share

  101. MORIERI ML, Shah H, Doria A
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2304-2305.
    >> Share

  102. HEGELE RA
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303-2304.
    >> Share

  103. CONTOU D, de Prost N
    Skin Mottling.
    N Engl J Med. 2016;375:2187.
    >> Share

    November 2016
  104. CORREIA LC, Latado A, Porzsolt F
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1798.
    >> Share

  105. COHEN S, Beckey C
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797.
    >> Share


  106. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-1799.
    >> Share

  107. ALVAREZ-VILLALOBOS NA, Trevino-Alvarez AM, Gonzalez-Gonzalez JG
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-8.
    >> Share

    October 2016
  108. BRAUNWALD E
    Treatment of Left Main Coronary Artery Disease.
    N Engl J Med. 2016.
    >> Share

  109. STONE GW, Sabik JF, Serruys PW, Simonton CA, et al
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
    N Engl J Med. 2016.
    >> Share

  110. MYLES PS, Smith JA, Forbes A, Silbert B, et al
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2016.
    >> Share

  111. LAMY A, Devereaux PJ, Prabhakaran D, Taggart DP, et al
    Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016.
    >> Share

  112. MOSLEHI JJ
    Cardiovascular Toxic Effects of Targeted Cancer Therapies.
    N Engl J Med. 2016;375:1457-1467.
    >> Share

  113. BUCHOLZ EM, Butala NM, Ma S, Normand ST, et al
    Life Expectancy after Myocardial Infarction, According to Hospital Performance.
    N Engl J Med. 2016;375:1332-1342.
    >> Share

    September 2016
  114. DWYER T, Sinaiko AR, Raitakari OT
    Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    >> Share

  115. SHARMA A, Lavie C
    Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    >> Share


  116. Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    >> Share

  117. MARSO SP, Bain SC, Consoli A, Eliaschewitz FG, et al
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2016.
    >> Share

  118. RAZA S, Blackstone EH, Sabik JF 3rd
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    >> Share

  119. BARBATO E, Toth GG, De Bruyne B
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    >> Share


  120. Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    >> Share

  121. GIANNONI A, Emdin M, Passino C
    Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea.
    N Engl J Med. 2016;375:1004-6.
    >> Share

    August 2016
  122. BATES ER
    Balancing the Evidence Base on Coronary Stents.
    N Engl J Med. 2016.
    >> Share

  123. BONAA KH, Mannsverk J, Wiseth R, Aaberge L, et al
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016.
    >> Share

  124. MOKHLESI B, Ayas NT
    Cardiovascular Events in Obstructive Sleep Apnea - Can CPAP Therapy SAVE Lives?
    N Engl J Med. 2016.
    >> Share

  125. MCEVOY RD, Antic NA, Heeley E, Luo Y, et al
    CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea.
    N Engl J Med. 2016.
    >> Share

  126. HU K, Xu W, Williams Z
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:703-4.
    >> Share

  127. DOEHNER W, Anker SD
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:703.
    >> Share

  128. BURSZTYN M
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:702-3.
    >> Share

  129. VISCOLI CM, Kernan WN, Young LH
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:704.
    >> Share

  130. BROTT TG, Voeks JH, Howard VJ
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:604-5.
    >> Share

  131. HUSSAIN MA, Al-Omran M
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:603.
    >> Share

  132. PARASKEVAS KI
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:602.
    >> Share

  133. SAMANTA A, Afzal MR
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:601-2.
    >> Share

  134. MATSUMURA J, Monteleone P, Rosenfield K
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:603-4.
    >> Share

  135. CHEN GC, Qin LQ
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:488.
    >> Share

  136. KOPEL E
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:488.
    >> Share

  137. LEOW MK
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:487-8.
    >> Share

  138. DU H, Li L, Chen Z
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:489.
    >> Share


  139. Sharing Data from Cardiovascular Clinical Trials--A Proposal.
    N Engl J Med. 2016;375:407-9.
    >> Share

    July 2016

  140. Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.
    N Engl J Med. 2016;375:398.
    >> Share

  141. BASSAN M
    Chronic Stable Angina.
    N Engl J Med. 2016;375:292-3.
    >> Share

  142. WANITSCHEK MM, Dorler J, Alber HF
    Chronic Stable Angina.
    N Engl J Med. 2016;375:292.
    >> Share

  143. OHMAN EM
    Chronic Stable Angina.
    N Engl J Med. 2016;375:293.
    >> Share

  144. LI WW, Wollersheim LW, Morshuis WJ
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:91.
    >> Share

  145. ALKHODAIR A, Cairns J
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:90-1.
    >> Share

  146. MYLES PS, Smith JA, Painter T
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:91-2.
    >> Share

    June 2016
  147. MARSO SP, Daniels GH, Brown-Frandsen K, Kristensen P, et al
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016.
    >> Share

  148. RADEMAKERS LM, Van Nunen LX
    IMAGES IN CLINICAL MEDICINE. Ventricular Septal Defect after Acute Myocardial Infarction.
    N Engl J Med. 2016;374:e28.
    >> Share

  149. COGSWELL ME, Mugavero K, Bowman BA, Frieden TR, et al
    Dietary Sodium and Cardiovascular Disease Risk - Measurement Matters.
    N Engl J Med. 2016.
    >> Share

    May 2016
  150. ALEXANDER JH, Smith PK
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;374:1954-64.
    >> Share

  151. NIOI P, Sigurdsson A, Thorleifsson G, Helgason H, et al
    Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.
    N Engl J Med. 2016.
    >> Share

  152. TYBJAERG-HANSEN A
    The Sialylation Pathway and Coronary Artery Disease.
    N Engl J Med. 2016.
    >> Share


  153. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
    N Engl J Med. 2016;374:1898.
    >> Share

  154. SAPP JL, Wells GA, Parkash R, Stevenson WG, et al
    Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
    N Engl J Med. 2016.
    >> Share

    April 2016
  155. MICHLER RE, Smith PK, Parides MK, Ailawadi G, et al
    Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.
    N Engl J Med. 2016.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016